From May 12, 2022 to June 30, 2022, the company has repurchased 797,000 shares, representing 0.14% for HKD 2.9 million. With this, the company has completed the repurchase of 797,000 shares, representing 0.14% for HKD 2.9 million under the buyback announced on May 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 HKD | 0.00% | -2.31% | +2.01% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.01% | 185M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.43% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.17% | 8.82B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.